SCHEMBL20178649

SCHEMBL20178649

CCN1CCCc2cc(C(=O)O)ccc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
MAPT P10636 3/20 0.52
KDM4E B2RXH2 2/20 0.52
GAA P10253 2/20 0.52
CASP1 P29466 2/20 0.52
HTT P42858 2/20 0.52
MEN1 O00255 1/20 0.52
LMNA P02545 1/20 0.52
TP53 P04637 1/20 0.52
CASP7 P55210 1/20 0.52
SMAD3 P84022 1/20 0.52
KMT2A Q03164 1/20 0.52
HSD17B10 Q99714 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
HDAC1 Q13547 7/20 0.49
HDAC6 Q9UBN7 7/20 0.49
HDAC8 Q9BY41 6/20 0.49
HDAC3 O15379 2/20 0.49
HDAC4 P56524 2/20 0.49
HDAC7 Q8WUI4 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20178650 0.92 ACHE (0.54) ALDH1A1MAPTKDM4EGAACASP1
SCHEMBL1310717 0.91 HDAC1 (0.49) ALDH1A1MAPTKDM4EGAACASP1
SCHEMBL18593240 0.90 GAA (0.54) ALDH1A1MAPTKDM4EGAACASP1
SCHEMBL20178669 0.88 ACHE (0.53) ALDH1A1MAPTKDM4EGAACASP1
SCHEMBL6858751 0.86 ALDH1A1 (0.53) ALDH1A1MAPTKDM4EGAACASP1
SCHEMBL6850945 0.85 HDAC1 (0.44) ALDH1A1MAPTKDM4EGAACASP1
SCHEMBL10473419 0.85 HRH3 (0.48) ALDH1A1MAPTKDM4EGAACASP1
SCHEMBL20178665 0.85 SRD5A1 (0.56) ALDH1A1MAPTKDM4EGAACASP1
SCHEMBL845803 0.85 ALDH1A1 (0.56) ALDH1A1MAPTKDM4EGAACASP1
SCHEMBL28291583 0.82 ALDH1A1 (0.49) ALDH1A1MAPTKDM4EGAACASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10597391-B2 Urea-containing isoxazole derivatives as FXR agonists and methods of use thereof ENANTA PHARMACEUTICALS, INC. (US) 2020-03-24 US disclosed
US-20180141941-A1 UREA-CONTAINING ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180141941-A1 UREA-CONTAINING ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF NR1H4, FXR1, SLC10A1 ALDH1A1 2185/4885MAPT 2493/4885KDM4E 4005/4885
US-10597391-B2 Urea-containing isoxazole derivatives as FXR agonists and methods of use thereof NR1H4, FXR1, SLC10A1 ALDH1A1 2185/4885MAPT 2493/4885KDM4E 4005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.